← Oncology Approval Tracker

FDA DECISION ·

Sorafenib (Nexavar first generic)

sorafenib · Mylan Pharmaceuticals

First generic approvalFirst genericLiver, kidney and differentiated thyroid cancers
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First generic Nexavar for unresectable hepatocellular carcinoma, advanced renal cell carcinoma, or progressive, locally recurrent or metastatic differentiated thyroid carcinoma refractory to radioactive iodine.

LAMPGEN ANALYSIS

Why it matters

Added a generic source of a multi-kinase inhibitor for three established cancer indications.

What research teams should watch

Reconcile labeled indication, dosing and supportive skin care when moving between products.

PRIMARY RECORDS

Sources